✦ LIBER ✦

PCN50 A PILOT STUDY ASSESSING THE QUALITY OF LIFE IMPACT OF ADVERSE EVENTS EXPERIENCED BY ADVANCED NON-SMALL-CELL LUNG CANCER PATIENTS RECEIVING SECOND-LINE CHEMOTHERAPY

✍ Scribed by D Tilden; G Hill; M Watt; S Bhalla

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The impact of chemotherapy on quality of

✍ Paccagnella, A; Favaretto, A; Villa, E; Barbieri, F; Ceresoli, G; Santo, A; DePa 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 255 KB

The impact of second-line agents on pati

✍ Arijit Ganguli, Phillip Wiegand, Xin Gao, John A. Carter… 📂 Article 📅 2012 🏛 Springer Netherlands 🌐 English ⚖ 319 KB

Efficacy and safety of erlotinib versus

✍ Tudor Ciuleanu; Lilia Stelmakh; Saulius Cicenas; Skaidrius Miliauskas; Alexandru 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 381 KB

First-cycle rash and survival in patient

✍ Ulrich Gatzemeier; Joachim von Pawel; Ihor Vynnychenko; Petr Zatloukal; Filippo 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 220 KB

PCN43 THE COST OF TREATING GRADE 3/4 ADV

✍ C Chouaid; A Vergnenegre; M Brunner; S Walzer 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PD-068 An exploratory analysis of a phas

✍ Bunn, P.; Rosell, R.; Fossella, F.; Perry, M.; Stahel, R.; Barata, F.; Nguyen, B 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB